欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体
Anti-uPAR mAbs [3C6 ](MABL-6276)
  • Anti-uPAR mAbs [3C6 ](MABL-6276)

Anti-uPAR mAbs [3C6 ](MABL-6276)

简要描述:

For Research Use Only. Not for diagnostic or therapeutic use.

产品参数:

Cat. No.:MABL-6276

Application:functional assay, inhibit, FC

Isotype:Engineer antibody

Species Reactivity:Human

Clone No.:3C6

产品价格:¥0

详细介绍
Cat. No.
MABL-6276
Application
functional assay, inhibit, FC
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
3C6
From
Recombinant Antibody
Specificity
This antibody binds human urokinase plasminogen activator receptor (uPAR). It does not cross react with mouse or cynomolgus monkey uPAR. Human uPAR plays a role in localizing and promoting plasmin formation. Mediates the proteolysis‑independent signal transduction activation effects of U‑PA. Upregulation of uPAR expression at the cell surface, and plasminogen activation, has been linked to a number of conditions including inflammation, wound repair, arthritis, atherosclerosis angiogenesis, tumor invasion and metastasis.
Alternative Names
CD87; U‑PAR; MO3; PLAUR; Urokinase plasminogen activator surface receptor; Monocyte activation antigen Mo3
UniProt
Q03405
Immunogen
The original antibody was isolated from a fully human naïve Fab phage display library constructed from the conversion of peripheral blood lymphocyte RNA into cDNA. The particular antibody clone was isolated by panning the library against human soluble uPAR that was immobilized to a Nunc Maxisorp™.
Application Notes
The binding affinity of the IgG antibody towards human uPAR was reported to be Kd= 230 pM (PMID: 23400595).This antibody binds cell surface uPAR and abrogates uPAR association with α5β1 and α3β1 integrin. In a cell adhesion assay this antibody was found to facilitate a decrease in fibronectin‑ or vitronectin‑dependent cell adhesion.
Antibody First Published
LeBeau et al. Targeting uPAR with Antagonistic Recombinant Human Antibodies in Aggressive Breast Cancer. Cancer Res. 2013 Feb 11;73(7):2070–2081. PMID:23400595
Note on publication
The paper demonstrates that uPAR is overexpressed in aggressive breast cancer subtypes and can be effectively targeted for both diagnostic imaging and therapeutic intervention. Using novel human anti-uPAR antibodies, the study shows successful tumor detection and reduction in preclinical breast cancer models, supporting uPAR as a promising target for future breast cancer diagnostics and treatments.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.

 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号